Ongoing research is vital to improving cancer survival rates. Research leads to a better understanding of cancer biology, which in turn drives the development of new treatments and diagnostic tools. Clinical trials test the efficacy and safety of new treatments and provide valuable data that can lead to FDA approval and widespread use. Institutions like the National Cancer Institute and organizations such as the American Cancer Society play crucial roles in funding and conducting cancer research.
